1. Home
  2. PRQR vs NVX Comparison

PRQR vs NVX Comparison

Compare PRQR & NVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • PRQR
  • NVX
  • Stock Information
  • Founded
  • PRQR 2012
  • NVX 2012
  • Country
  • PRQR Netherlands
  • NVX Australia
  • Employees
  • PRQR N/A
  • NVX N/A
  • Industry
  • PRQR Biotechnology: Pharmaceutical Preparations
  • NVX Industrial Machinery/Components
  • Sector
  • PRQR Health Care
  • NVX Miscellaneous
  • Exchange
  • PRQR Nasdaq
  • NVX Nasdaq
  • Market Cap
  • PRQR 224.4M
  • NVX 204.1M
  • IPO Year
  • PRQR 2014
  • NVX N/A
  • Fundamental
  • Price
  • PRQR $2.80
  • NVX $1.75
  • Analyst Decision
  • PRQR Strong Buy
  • NVX
  • Analyst Count
  • PRQR 8
  • NVX 0
  • Target Price
  • PRQR $8.88
  • NVX N/A
  • AVG Volume (30 Days)
  • PRQR 649.8K
  • NVX 8.1M
  • Earning Date
  • PRQR 11-07-2025
  • NVX 01-01-0001
  • Dividend Yield
  • PRQR N/A
  • NVX N/A
  • EPS Growth
  • PRQR N/A
  • NVX N/A
  • EPS
  • PRQR N/A
  • NVX N/A
  • Revenue
  • PRQR $20,129,184.00
  • NVX $5,931,433.00
  • Revenue This Year
  • PRQR N/A
  • NVX $165.90
  • Revenue Next Year
  • PRQR N/A
  • NVX $1,344.85
  • P/E Ratio
  • PRQR N/A
  • NVX N/A
  • Revenue Growth
  • PRQR 8.65
  • NVX N/A
  • 52 Week Low
  • PRQR $1.07
  • NVX $0.81
  • 52 Week High
  • PRQR $4.21
  • NVX $3.86
  • Technical
  • Relative Strength Index (RSI)
  • PRQR 60.30
  • NVX 47.68
  • Support Level
  • PRQR $2.71
  • NVX $1.66
  • Resistance Level
  • PRQR $3.00
  • NVX $2.07
  • Average True Range (ATR)
  • PRQR 0.24
  • NVX 0.42
  • MACD
  • PRQR 0.01
  • NVX -0.08
  • Stochastic Oscillator
  • PRQR 71.11
  • NVX 5.10

About PRQR ProQR Therapeutics N.V.

ProQR Therapeutics NV is a biopharmaceutical company. It discovers and develops RNA therapeutics for patients with severe genetic rare diseases such as cystic fibrosis, Leber congenital amaurosis type 10, and dystrophic epidermolysis bullosa. The only reportable segment of the company is the discovery and development of different, RNA-based therapeutics.

About NVX NOVONIX Limited American Depository Shares

NOVONIX Ltd operates in the lithium-ion battery industry. The company has three operating segments namely Graphite Exploration, Battery Technology, and Battery Materials. Graphite Exploration segment is engaged in the exploration and development of high-grade flake graphite deposits. The Battery Technology segment develops battery cell testing equipment and carries out research and development in battery development. The Battery Materials segment develops and manufactures battery anode materials. The Battery Technology segment generates maximum revenue for the company.

Share on Social Networks: